Advances in the Development of Nonpeptide Small Molecules

Por um escritor misterioso

Descrição

Advances in the Development of Nonpeptide Small Molecules
Recent progress in developing small molecule inhibitors designed to interfere with ras membrane association: toward inhibiting K-Ras and N-Ras functions.
Advances in the Development of Nonpeptide Small Molecules
Covalent Small Molecule Immunomodulators Targeting the Protease Active Site
Advances in the Development of Nonpeptide Small Molecules
Chemokines, chemokine receptors and small-molecule antagonists: recent developments: Trends in Pharmacological Sciences
Advances in the Development of Nonpeptide Small Molecules
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Advances in the Development of Nonpeptide Small Molecules
Novel small molecules affecting cell membrane as potential therapeutics for avian pathogenic Escherichia coli
Advances in the Development of Nonpeptide Small Molecules
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor
Advances in the Development of Nonpeptide Small Molecules
Recent progress in developing small molecule inhibitors designed to interfere with ras membrane association: toward inhibiting K-Ras and N-Ras functions.
Advances in the Development of Nonpeptide Small Molecules
Small molecule screen in embryonic zebrafish using modular variations to target segmentation
Advances in the Development of Nonpeptide Small Molecules
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor
Advances in the Development of Nonpeptide Small Molecules
Drugability of Extracellular Targets: Discovery of Small Molecule Drugs Targeting Allosteric, Functional, and Subunit-Selective Sites on GPCRs and Ion Channels
Advances in the Development of Nonpeptide Small Molecules
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021, Journal of Hematology & Oncology
Advances in the Development of Nonpeptide Small Molecules
Molecular models of the nonpeptide agonists in complex with the ghrelin
Advances in the Development of Nonpeptide Small Molecules
Full article: Cinchonine, a Potential Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist, Lowers Blood Glucose and Ameliorates Non-Alcoholic Steatohepatitis
de por adulto (o preço varia de acordo com o tamanho do grupo)